|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Etiology, pathogenesis, and diagnosis of neovascular glaucoma显示文摘Neovascular glaucoma is defined as iris and/or anterior chamber angle neovascularization associated with increased intraocular pressure. It is a secondary glaucoma that is most frequently caused by severe retinal ischemia. The most common diseases responsible for the development of neovascular glaucoma are diabetic retinopathy, ischemic central retinal vein occlusion,and ocular ischemic syndrome. Uncommon causes include ocular radiation, ocular tumors, uveitis and other miscellaneous conditions. Vascular endothelial growth factor is an important and likely predominant agent involved in the pathogenesis of intraocular neovascularization and neovascular glaucoma. The evolution of clinical and histopathological changes from predisposing conditions to the occurrence of rubeosis iridis and neovascular glaucoma is divided into four stages: prerubeosis, preglaucoma, open angle glaucoma, and angle-closure glaucoma. | Dan Calugaru Mihai Calugaru | 2022 | International Journal of Ophthalmology(English edition)2022,15,6: | 4 |
| 2 | Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management显示文摘● AIM: To prospectively evaluate the cumulative prevalence and the management of ocular hypertension(OH) in patients with unilateral acute central/hemicentral retinal vein occlusions(C/HCRVOs) over the course of 3 y.● METHODS: The study included 57 patients with unilateral acute C/HCRVOs. All patients underwent a comprehensive ophthalmological examination of both eyes. OH associated with C/HCRVO in patients showing a score >5% for the risk of conversion to primary open angle glaucoma(POAG) was treated with OH medication. The treatment aimed for a decrease in intraocular pressure(IOP) to <21 mm Hg with a >22% reduction from the initial values. The cumulative prevalence of OH and the effectiveness of treatment assessed by the cumulative prevalence of conversion from OH to POAG, were estimated.● RESULTS: Fifteen patients had OH associated with C/HCRVOs, the cumulative prevalence of OH was 29.4%(95% confidence interval, 16.9-41.9). The mean value of the risk score of OH conversion to POAG for the 5 subsequent years was 11.7%±5.4%. The IOP significantly decreased from 25.67±2.16 mm Hg to 18.73±2.96 mm Hg. None of the OH patients converted to POAG during the follow-up period. ● CONCLUSION: The increased cumulative prevalence of OH in C/HCRVO patients indicates that OH is a risk factor for the appearance of venous occlusion. Patients with OH associated with C/HCRVO must be considered to be at high risk for conversion to POAG. Treatment with OH medications prevented conversion to POAG during the 3-year follow-up. | Dan Calugaru Mihai Calugaru Stefan Talu | 2018 | International Journal of Ophthalmology(English edition)2018,11,7: | 2 |
| 3 | 12-year outcomes following permanent prostate brachytherapy in patients with clinical- ly localiged prostate cancer显示文摘 | Potters L Morgenstern C Calugaru E | 2005 | J Urol2005,173,5: | 1 |
| 4 | Seismic Response of 20-story Base-isolated and Fixed-base Reinforced Concrete Structural Wall Buildings at a Near-fault Site 显示文摘 | Calugaru V Panagiotou M | 2014 | Earthquake Engineering & Structural Dynamics2014,43,92: | 1 |
| 5 | The estimation of phase modifications in polymers by the method of “molecular probes”in gas chromatography-IV:Glass transition behaviour and compatibility in mixtures of poly(vinyl chloride)-polystyrene and poly(vinyl chloride)-polyaerylonitrile显示文摘 | I A Schneider E M Calugaru | 1976 | Eur Polym J1976,12,: | 1 |
| 6 | Comment on 'Intravitreal dexamethasone implants for diabetic macular edema'显示文摘Dear Editor,We would like to address several issues with the study of Pareja-Rios et al[1].The study was retrospectively conducted and 3mo of treatment with laser or anti-vascular endothelial growth factor (VEGF) agents mean a period of time too short to label a patient as nonresponder to these therapies. | Dan Calugaru Mihai Calugaru | 2018 | International Journal of Ophthalmology(English edition)2018,11,12: | 1 |
| 7 | Chondrosarcomas of the base of the skull in Ollier's disease or Maffucci's syndrome-three case reports and review of the literature显示文摘 | Noel G Feuvret L Calugaru V | 2004 | Acta Oncol2004,43,8: | 1 |
| 8 | 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer 显示文摘 | Potters L Morgenstern C Calugaru E | 2005 | J Urol2005,173,5: | 1 |
| 9 | Chondromyxoid fibro- ma of the skull base : differential diagnosis and radiothera- py:two case reports and a review of the literature显示文摘 | Feuvret L No~l G Calugaru V | 2005 | Acta 0ncol2005,44,6: | 1 |
| 10 | 12-year outeomes following permanent postate brachytherapy in Patients with clinically localized prostate cancer显示文摘 | Potters L Morgenstem C Calugaru E | | 0,,05: | 1 |
| 11 | Clay-clast aggregates:A new textural evidence for seismic fault sliding显示文摘 | Boutareaud S Fabbri O Calugaru D | | 0,,: | 1 |
| 12 | 12-year outcomes following permanent prostate brachytherapy in patients with elinically localized prostate cancer显示文摘 | Potters L Morgenstern C Calugaru E | | 0,,: | 1 |
| 13 | Seismic response of 20 - story base - isolated and fixed - base reinforced concrete structural wall buildings at a near - fault site 显示文摘 | Calugaru V Panagiotou M | 2014 | Earthquake Engineering & Structural Dynamics2014,43,6: | 1 |
| 14 | Comment on “Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema:a retrospective cohort study”显示文摘Dear Editor,The study by Mastropasqua et al[1]evaluated the efficacy and safety of ranibizumab(Lucentis;Genentech,Inc.,South San Francisco,CA,USA;RBZ group)and dexamethasone implant(Ozurdex;Allergan Irvine.,CA,USA;DEX group)intravitreal treatments in 50 patients with treatment-naive center involved diabetic macular edema(DME)by means of functional and morphological assessments during a 6-month follow-up. | Dan Calugaru Mihai Calugaru | 2020 | International Journal of Ophthalmology(English edition)2020,13,10: | 1 |
| 15 | Static mag- netic field influence on some plant growth显示文摘 | RACUCIU M CALUGARU G H CREANGA D E | 2006 | Romanian J Phys2006,51,12: | 1 |
| 16 | Comment on: Real-world outcomes of two-year Conbercept therapy for diabetic macular edema显示文摘Dear Editor,We read with great interest the study by Cheng et al[1], which assessed the two-year outcomes in 30(36 eyes) diabetic macular edema(DME) patients treated with intravitreal conbercept(Lumitin;Chengdu Kanghong Biotech Xo, Ltd, China;IVC) for 3 mo. | Dan Calugaru Mihai Calugaru | 2022 | International Journal of Ophthalmology(English edition)2022,15,4: | 1 |
| 17 | 12-year outcomes following permanent prostate brachytherapy in patients with cli- nically localized prostate cancer 显示文摘 | Potters L Morgenstern C Calugaru E | 2008 | J Urol2008,179,5: | 1 |
| 18 | Comment on “Management strategies in malignant glaucoma secondary to antiglaucoma surgery”显示文摘Dear Editor,We read with great interest the article by Wu et al[1]which comprehensively assessed the outcomes of various interventions in 38 eyes of 35 patients with malignant glaucoma(MG)secondary to antiglaucoma surgery | Dan Calugaru Mihai Calugaru | 2018 | International Journal of Ophthalmology(English edition)2018,11,8: | 1 |
| 19 | Seismic response of 20-story base-isolated and fixed-base reinforced concrete structural wall buildings at a near-fault site 显示文摘 | CALUGARU V PANAGIOTOU M | 2014 | Earthquake Engineering & Structural Dynamics2014,43,6: | 1 |
| 20 | Seismic response of 20-story base-isolated and fixed-base reinforced concrete structural wall buildings at a near-fault site显示文摘 | Calugaru V Panagiotou M | 2014 | Earthquake Engineering & Structural Dynamics2014,43,: | 1 |